ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 663

$554K Total Retail Price of All Prescriptions

Rank: 52 out of 663

547 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

6% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,563 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 424 397 1 1
LEVOTHYROXINE SODIUM 374 357 2 3
LISINOPRIL 276 263 3 2
WARFARIN SODIUM 240 240 4 8
METOPROLOL TARTRATE 175 172 5 11
AMLODIPINE BESYLATE 171 159 6 5
ATORVASTATIN CALCIUM 164 149 7 13
HYDROCHLOROTHIAZIDE 152 149 8 12
OMEPRAZOLE 144 139 9 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 126 10 22
HYDROCODONE-ACETAMINOPHEN 128 111 S3 11 6
METFORMIN HCL 116 105 12 9
CRESTOR 111 101 13 37
METOPROLOL SUCCINATE 109 109 14 25
FUROSEMIDE 105 105 15 7
ZOLPIDEM TARTRATE 105 85 15 16
CITALOPRAM HBR 98 98 17 18
TAMSULOSIN HCL 98 96 17 24
ALLOPURINOL 96 89 19 28
ALENDRONATE SODIUM 93 93 20 15
PRAVASTATIN SODIUM 92 91 21 21
LIPITOR 92 88 21 72
LOVASTATIN 89 88 23 30
LOSARTAN POTASSIUM 87 85 24 14
SYNTHROID 87 79 24 46
POTASSIUM CHLORIDE 85 85 26 23
LEVOXYL 78 78 27 133
PREMARIN 71 66 R 28 156
SERTRALINE HCL 70 68 29 35
PANTOPRAZOLE SODIUM 70 70 29 45
CLONIDINE HCL 63 57 31 79
GLYBURIDE-METFORMIN HCL 63 59 R 31 131
NAMENDA 59 59 33 57
ATENOLOL 58 54 34 10
DIOVAN 58 58 34 59
TRAMADOL HCL 58 54 34 17
TRAZODONE HCL 56 56 37 34
EVISTA 56 56 37 150
BYSTOLIC 56 56 37 116
DONEPEZIL HCL 54 54 40 40
MOEXIPRIL-HYDROCHLOROTHIAZIDE 52 52 41 324
GLYBURIDE 52 46 R 41 83
CARVEDILOL 52 51 41 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.